Pathology Associates Rockland is categorized under Pathological Laboratories in Suffern, NY and active since 2002.
Pathology Associates Rockland was established in 2002, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Thomas Snopek at the company’s single location by writing to 255 Lafayette Avenue Floor 1, Suffern, New York NY 10901 or by phoning (845) 368-5179. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pathology Associates Rockland |
| Contact Person: | Thomas Snopek |
| Address: | 255 Lafayette Avenue Floor 1, Suffern, New York 10901 |
| Phone Number: | (845) 368-5179 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Pathological Laboratories |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Pathology Associates Rockland was started in 2002 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Thomas Snopek for inquiries that concern Pathology Associates Rockland by calling the company number (845) 368-5179, as your correspondence is most welcome. Additionally, the physical location of the single location of Pathology Associates Rockland can be found at the coordinates 41.112117,-74.133661 as well as the street address 255 Lafayette Avenue Floor 1 in Suffern, New York 10901.
For its online presence, you may visit Pathology Associates Rockland’s website at and engage with its social media outlets through on Twitter and on Facebook.